|
PEN | Penumbra Inc |
|
|
PEN | Penumbra Inc |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 0.13 |
| Leverage | 22.11% |
| Market Cap | $ 10.8B |
| PE | 65.99 |
| Dividend Yield | 0.00% |
| Profit | $ 163.5m |
| Margin | 12.30% |
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company is headquartered in Alameda, California.